GlaxoSmithKline plc Profile

USD 0.25  0.61%
40.38Last Month High 41.08 
40.93Trading Day  High 41.08 

GlaxoSmithKline plc Summary

GlaxoSmithKline plc (GSK) is traded on New York Stock Exchange in USA. It is located in UNITED KINGDOM and employs 101,255 people. GlaxoSmithKline plc is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 95.09 B. GlaxoSmithKline plc has 4.89 B outstanding shares of which 4.58 M shares are currently shorted by investors with about 1.71 days to cover shorted positions. GLAXOSMITHKLINE P has about 5.44 B in cash with 9.12 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.23.
Check GlaxoSmithKline plc Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected GlaxoSmithKline plc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

GlaxoSmithKline plc Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
< 29% 
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, overthecounter medicines, and healthrelated consumer solutions worldwide. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameGlaxoSmithKline plc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
InstrumentUSA Stock Stocks Directory
Business Address980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom
Foreign Associates
ExchangeNew York Stock Exchange
CIK Number01131399.0
IndustryPharmaceutical Products
Contact Number(44) 20 8047 7807
CurrencyUSD - US Dollar


GlaxoSmithKline plc Analyst Recommendations
Target PriceAdvice# of Analysts
GlaxoSmithKline plc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
GlaxoSmithKline plc Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


GlaxoSmithKline plc Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.59April 26, 2017
GlaxoSmithKline plc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate